Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Chennamsetty Indumathi |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Vinod, M; Chennamsetty, I; Colin, S; Belloy, L; De Paoli, F; Schaider, H; Graier, W; Frank, S; Kratky, D; Staels, B; Chinetti-Gbaguidi, G; Kostner, G
MIR-206 CONTROLS LXR-ALPHA EXPRESSION AND PROMOTES LXR-MEDIATED CHOLESTEROL EFFLUX IN MACROPHAGES
ATHEROSCLEROSIS. 2014; 235(2):E39-E39.-82nd Congress of the European-Atherosclerosis-Society (EAS); MAY 31-JUN 03, 2014; Madrid, SPAIN.
Doi: 10.1016/j.atherosclerosis.2014.05.084
[Poster]
Web of Science
FullText
FullText_MUG
Chennamsetty, I; Kostner, G
ROLE OF FARNESOID X RECEPTOR AGONISTS IN THE IN VIVO AND IN VITRO EXPRESSION OF APOLIPOPROTEIN(a)
ATHEROSCLER SUPPL. 2010; 11(2): P210
Doi: 10.1016/S1567-5688(10)70277-4
[Poster]
Web of Science
FullText
FullText_MUG
Chennamsetty, I; Kostner, GM
Role of bile acids in the transcriptional regulation of apo(a) in vivo and in vitro
Austrian Atherosclerosis Society(AAS); May 2010; St. Gilgen, Austria. 2010.
[Oral Communication]
Chennamsetty, I; Kostner, GM
FXR ligands suppress hepatic apolipoprotein(a) expression
keystone symposia, Bioactive Lipids: Biochemistry and Diseases (D2); june 2010; Kyoto, Japan. 2010.
[Poster]